Literature DB >> 22678179

Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale.

Angelo Antonini1, Giovanni Abbruzzese, Luigi Ferini-Strambi, Barbara Tilley, Jing Huang, Glenn T Stebbins, Christopher G Goetz, Paolo Barone, Monica Bandettini di Poggio, Giovanni Fabbrini, Flavio Di Stasio, Michele Tinazzi, Tommaso Bovi, Silvia Ramat, Sara Meoni, Gianni Pezzoli, Margherita Canesi, Paolo Martinelli, Cesa Lorella Maria Scaglione, Aroldo Rossi, Nicola Tambasco, Gabriella Santangelo, Marina Picillo, Letterio Morgante, Francesca Morgante, Rocco Quatrale, MariaChiara Sensi, Manuela Pilleri, Roberta Biundo, Giampietro Nordera, Antonella Caria, Claudio Pacchetti, Roberta Zangaglia, Leonardo Lopiano, Maurizio Zibetti, Mario Zappia, Alessandra Nicoletti, Aldo Quattrone, Maria Salsone, Gianni Cossu, Daniela Murgia, Alberto Albanese, Francesca Del Sorbo.   

Abstract

The Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) has been available in English since 2008. As part of this process, the MDS-UPDRS organizing team developed guidelines for development of official non-English translations. We present here the formal process for completing officially approved non-English versions of the MDS-UPDRS and specifically focus on the first of these versions in Italian. The MDS-UPDRS was translated into Italian and tested in 377 native-Italian speaking PD patients. Confirmatory and exploratory factor analyses determined whether the factor structure for the English-language MDS-UPDRS could be confirmed in data collected using the Italian translation. To be designated an 'Official MDS translation,' the Comparative Fit Index (CFI) had to be ≥0.90 relative to the English-language version. For all four parts of the Italian MDS-UPDRS, the CFI, in comparison with the English-language data, was ≥0.94. Exploratory factor analyses revealed some differences between the two datasets, however these differences were considered to be within an acceptable range. The Italian version of the MDS-UPDRS reaches the criterion to be designated as an Official Translation and is now available for use. This protocol will serve as outline for further validation of this in multiple languages.

Entities:  

Mesh:

Year:  2012        PMID: 22678179     DOI: 10.1007/s10072-012-1112-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

1.  Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).

Authors:  Christopher G Goetz; Glenn T Stebbins; Teresa A Chmura; Stanley Fahn; Werner Poewe; Caroline M Tanner
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 2.  The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.

Authors: 
Journal:  Mov Disord       Date:  2003-07       Impact factor: 10.338

3.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

4.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

Authors:  Christopher G Goetz; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Glenn T Stebbins; Matthew B Stern; Barbara C Tilley; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J Van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

  4 in total
  33 in total

1.  Handling missing values in the MDS-UPDRS.

Authors:  Christopher G Goetz; Sheng Luo; Lu Wang; Barbara C Tilley; Nancy R LaPelle; Glenn T Stebbins
Journal:  Mov Disord       Date:  2015-02-04       Impact factor: 10.338

2.  Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?

Authors:  Angela Federico; Michela Trentin; Giampietro Zanette; Daniela Mapelli; Alessandro Picelli; Nicola Smania; Michele Tinazzi; Stefano Tamburin
Journal:  Neurol Sci       Date:  2017-05-26       Impact factor: 3.307

3.  Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale.

Authors:  Rwei-Ling Yu; Ruey-Meei Wu; Anne Y Y Chan; Vincent Mok; Yih-Ru Wu; Barbara C Tilley; Sheng Luo; Lu Wang; Nancy R LaPelle; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord Clin Pract       Date:  2016-04-08

4.  MRI gray and white matter measures in progressive supranuclear palsy and corticobasal syndrome.

Authors:  Neeraj Upadhyay; Antonio Suppa; Maria Cristina Piattella; Matteo Bologna; Flavio Di Stasio; Alessandra Formica; Francesca Tona; Carlo Colosimo; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2016-07-13       Impact factor: 4.849

5.  Freezing of gait in Parkinson's disease: gray and white matter abnormalities.

Authors:  Sara Pietracupa; Antonio Suppa; Neeraj Upadhyay; Costanza Giannì; Giovanni Grillea; Giorgio Leodori; Nicola Modugno; Francesca Di Biasio; Alessandro Zampogna; Claudio Colonnese; Alfredo Berardelli; Patrizia Pantano
Journal:  J Neurol       Date:  2017-11-11       Impact factor: 4.849

6.  Effect of different music genres on gait patterns in Parkinson's disease.

Authors:  D De Bartolo; G Morone; G Giordani; G Antonucci; V Russo; A Fusco; F Marinozzi; F Bini; G F Spitoni; S Paolucci; M Iosa
Journal:  Neurol Sci       Date:  2019-11-12       Impact factor: 3.307

7.  A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson's disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study.

Authors:  Riccardo Calvani; Anna Picca; Giovanni Landi; Federico Marini; Alessandra Biancolillo; Hélio José Coelho-Junior; Jacopo Gervasoni; Silvia Persichilli; Aniello Primiano; Annalaura Arcidiacono; Andrea Urbani; Maurizio Bossola; Anna Rita Bentivoglio; Matteo Cesari; Roberto Bernabei; Maria Rita Lo Monaco; Emanuele Marzetti
Journal:  Geroscience       Date:  2020-05-26       Impact factor: 7.713

8.  Dynamic functional connectivity changes associated with dementia in Parkinson's disease.

Authors:  Eleonora Fiorenzato; Antonio P Strafella; Jinhee Kim; Roberta Schifano; Luca Weis; Angelo Antonini; Roberta Biundo
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

9.  Spectrum of cognitive disorders in idiopathic normal pressure hydrocephalus.

Authors:  Marta Picascia; B Minafra; Roberta Zangaglia; L Gracardi; N G Pozzi; E Sinforiani; Claudio Pacchetti
Journal:  Funct Neurol       Date:  2016 Jul-Sep

10.  Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS).

Authors:  Gabriella Santangelo; Paolo Barone; Giovanni Abbruzzese; Luigi Ferini-Strambi; Angelo Antonini
Journal:  Neurol Sci       Date:  2013-09-25       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.